首页> 美国卫生研究院文献>Cell Death Disease >Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death
【2h】

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death

机译:抗癌化学疗法和放射疗法会触发非细胞自主死亡和细胞自主死亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Even though cell death modalities elicited by anticancer chemotherapy and radiotherapy have been extensively studied, the ability of anticancer treatments to induce non-cell-autonomous death has never been investigated. By means of multispectral imaging flow-cytometry-based technology, we analyzed the lethal fate of cancer cells that were treated with conventional anticancer agents and co-cultured with untreated cells, observing that anticancer agents can simultaneously trigger cell-autonomous and non-cell-autonomous death in treated and untreated cells. After ionizing radiation, oxaliplatin, or cisplatin treatment, fractions of treated cancer cell populations were eliminated through cell-autonomous death mechanisms, while other fractions of the treated cancer cells engulfed and killed neighboring cells through non-cell-autonomous processes, including cellular cannibalism. Under conditions of treatment with paclitaxel, non-cell-autonomous and cell-autonomous death were both detected in the treated cell population, while untreated neighboring cells exhibited features of apoptotic demise. The transcriptional activity of p53 tumor-suppressor protein contributed to the execution of cell-autonomous death, yet failed to affect the non-cell-autonomous death by cannibalism for the majority of tested anticancer agents, indicating that the induction of non-cell-autonomous death can occur under conditions in which cell-autonomous death was impaired. Altogether, these results reveal that chemotherapy and radiotherapy can induce both non-cell-autonomous and cell-autonomous death of cancer cells, highlighting the heterogeneity of cell death responses to anticancer treatments and the unsuspected potential contribution of non-cell-autonomous death to the global effects of anticancer treatment.
机译:尽管已经广泛研究了由抗癌化学疗法和放射疗法引起的细胞死亡方式,但从未研究过抗癌疗法诱导非细胞自主死亡的能力。借助基于流式细胞仪的多光谱成像技术,我们分析了用常规抗癌药治疗并与未处理细胞共培养的癌细胞的致命命运,观察到抗癌药可以同时触发细胞自主和非细胞凋亡。经处理和未经处理的细胞中的自主死亡。电离辐射,奥沙利铂或顺铂治疗后,通过细胞自主死亡机制消除了部分治疗的癌细胞群,而其他部分治疗过的癌细胞则通过非细胞自主过程吞噬并杀死了邻近细胞,包括细胞食人症。在用紫杉醇治疗的条件下,在处理的细胞群中均检测到非细胞自主死亡和细胞自主死亡,而未处理的邻近细胞则显示出凋亡的死亡特征。 p53肿瘤抑制蛋白的转录活性有助于执行细胞自主死亡,但对于大多数测试的抗癌药物而言,吞噬作用均无法影响非细胞自主死亡,这表明非细胞自主性的诱导死亡可以在细胞自主死亡受损的情况下发生。总而言之,这些结果表明化学疗法和放射疗法可以诱导癌细胞的非细胞自主死亡和细胞自主死亡,突出了细胞死亡对抗癌治疗反应的异质性以及非细胞自主死亡对肿瘤的潜在影响。抗癌治疗的全球效应。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号